PON2 expression has been reported to be influenced by p53 and PON2 knockdown in pancreatic ductal adenocarcinoma cell (PDAC) cell lines inhibits tumour growth and alters glucose metabolism (Nagarajan et al. 2017). Here, PON2 is linked to pancreatic ductal adenocarcinoma.